Why International Expertise Often Makes Things Worse

By Ali Alqeisi | Strategic Partnerships, Marketing & Communications Manager, Emerging Health International

It arrives with impressive credentials. A team of international consultants — trained at globally recognised institutions, experienced across multiple continents, armed with frameworks refined in high-income healthcare systems. They assess. They recommend. They present. And then, typically within months, they leave.

The strategy document is thorough. The recommendations are technically sound. And the impact, in most cases, is negligible.

This is one of the most uncomfortable truths in global health: international expertise, deployed without contextual adaptation, does not just fail to help, it can actively make things worse. It misdiagnoses problems, misaligns solutions, and leaves behind a trail of abandoned frameworks that erode local confidence and waste institutional resources.

Understanding why this happens and what to do instead , is essential for any healthcare leader, investor, or policymaker working in emerging markets today.

The Credibility Trap

There is a powerful and understandable logic to importing expertise. Emerging market health systems face genuine and complex challenges. International consultants bring exposure to systems that have , in some respects , solved problems that these markets are still grappling with. The credibility of a globally recognised firm or institution carries weight with boards, ministries, and donors.

But credibility built in one context does not automatically transfer to another. And the assumption that it does is where the problem begins.

A landmark study published in the Indian Journal of Community Medicine made this point precisely: adapting generic strategies and tools to provide local solutions for local problems is the optimal way of solving quality problems in resource-constrained settings. The key point, the authors noted, is that international frameworks must be used as “good starting points”, not finished solutions. “We must shape and size the wheel to suit our healthcare vehicle.” (NCBI, 2009)

Too often, the wheel arrives already sized. For a different vehicle. In a different market. On different roads.

The Evidence Problem

The misalignment runs deeper than process. It runs through the very evidence base that international expertise relies upon.

Research published in PLOS Medicine highlights a critical and frequently overlooked gap: the vast majority of clinical and healthcare management evidence is generated in high-income countries and may not be applicable in lower-resource settings. In developing countries, “treatments that would be delivered by doctors elsewhere are often delivered by medical assistants or clinical officers” — and the most effective intervention in a randomised controlled trial may not be the most effective intervention when provided in a different context. (PLOS Medicine, 2005)

This matters enormously when international consultants arrive with recommendations built on evidence bases that were never designed with emerging market realities in mind.

A striking illustration comes from research on Arab healthcare systems: across all Arab countries, medical research production over an 18-year period represented just 3% of United States production. This means that, in the best case scenario, 97% of clinical practice in these countries is based on evidence not specifically generated for them — evidence that may not account for different disease profiles, different workforce structures, different cultural dynamics, or different resource constraints. (NCBI, 2016)

When international expertise arrives built on that 97%, and presents it as universal truth, the foundations are already compromised.

Three Things That Get Ignored

In practice, international expertise deployed in emerging market healthcare consistently underestimates three critical factors:

1. Workforce Reality

International frameworks are designed around workforce structures, skill distributions, and staffing ratios that simply do not exist in many emerging markets. A care pathway that functions beautifully in a hospital with a 1:4 nurse-to-patient ratio breaks down immediately in a facility running at 1:12.

Research from the NCBI Bookshelf on improving quality of care in developing countries found that quality failures in these settings “represent neither the failure of professional commitment nor the inevitable result of resource constraints” — they represent the failure to align interventions with the actual workforce capacity available. (NCBI Bookshelf)

Recommendations that ignore this reality are not just unhelpful. They are demoralising to the workforce expected to implement them.

2. Cultural and Operational Context

Healthcare is not culturally neutral. Patient behaviour, family involvement in care decisions, community trust in health institutions, communication norms between clinical hierarchies, these factors vary enormously across emerging markets and profoundly affect how care is delivered and received.

International expertise that parachutes in without deep engagement with these dynamics produces recommendations that are technically correct and practically unworkable. As the Speyside Group’s 2024-2025 Emerging Markets Healthcare Outlook notes, “the traditional siloed approach to healthcare policy is no longer adequate” — a holistic, contextually grounded approach is essential. (Speyside Group, 2024)

3. Implementation Infrastructure

Perhaps the most consistently underestimated factor is the infrastructure required to implement recommendations. High-income healthcare systems have decades of accumulated operational infrastructure — regulatory bodies, professional associations, quality monitoring systems, supply chains, data systems — that support the implementation of new models.

In many emerging markets, this infrastructure is partial, fragile, or absent. Recommendations that assume its existence fail not because of bad intent but because they were never designed for the environment they are being dropped into.

Research on developing countries’ health policy identifies “weak governance and accountability arrangements” as a persistent barrier that “frequently undermines value for money, service quality, and public trust” — even when the underlying recommendations are technically sound. (ResearchGate, 2024)

Why the Consulting Model Compounds the Problem

The failure of international expertise in emerging markets is not solely a knowledge problem. It is a structural problem , built into the consulting model itself.

The traditional engagement model — assess, recommend, present, depart , is fundamentally misaligned with the complexity of healthcare transformation in resource-constrained settings. It optimises for deliverables: reports, frameworks, presentations. It does not optimise for outcomes: functioning systems, embedded behaviour change, sustained performance improvement.

This structural misalignment has a predictable consequence. Recommendations are handed over to organisations that lack the capacity to implement them, without the sustained support needed to bridge that gap. The framework sits on a shelf. The consultant’s invoice is paid. Nothing changes.

What makes this particularly damaging is what it does to institutional confidence. When internationally credentialled expertise is seen to fail repeatedly, it breeds a corrosive cynicism toward improvement efforts, making future transformation attempts harder to launch and harder to sustain.

What Context-Sensitive Implementation Actually Looks Like

The alternative to imported expertise is not the rejection of global knowledge. The global evidence base, international best practices, and cross-market learning are genuinely valuable — when applied correctly.

Context-sensitive implementation means:

Starting with honest assessment, not pre-built frameworks. Understanding what actually exists — the workforce, the infrastructure, the cultural dynamics, the governance structures, before designing any intervention.

Adapting global knowledge to local reality. Not copying models. Translating principles. The evidence base from high-income settings is a starting point, not a blueprint.

Staying through implementation. The gap between recommendation and working system is where transformation lives. Closing that gap requires presence, iteration, and sustained commitment , not a handover meeting.

Building local capacity alongside delivering solutions. Every engagement should leave the organisation more capable of solving its next problem independently. Dependency on external expertise is not a sustainable model for any healthcare system.

This approach is more demanding. It requires deeper contextual knowledge, longer engagement timelines, and a willingness to sit with complexity rather than resolve it prematurely into a tidy framework.

But it is the only approach that actually works.

The Measure That Matters

The measure of successful healthcare transformation is not the quality of the strategy document. It is whether the system functions better after the external partner leaves than it did before they arrived.

By that measure, the track record of internationally deployed expertise in emerging markets is, at best, mixed. The frameworks are often sound. The contextual fit is often poor. The implementation support is often absent. And the lasting impact is often minimal.

Healthcare leaders in emerging markets deserve better than impressive credentials that don’t translate. They deserve partners who understand that global expertise and local execution are not alternatives — they are both necessary, and neither is sufficient without the other.

References

NCBI / Indian Journal of Community Medicine (2009). Can We Transplant Conceptual Frameworks of Healthcare Quality Evaluation from Developed Countries into Developing Countries? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781134/
PLOS Medicine / NCBI (2005). Is Evidence-Based Medicine Relevant to the Developing World? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1140939/
NCBI (2016). How to implement medical evidence into practice in developing countries. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056025/
NCBI Bookshelf. Improving the Quality of Care in Developing Countries — Disease Control Priorities in Developing Countries. https://www.ncbi.nlm.nih.gov/books/NBK11790/
Speyside Group (2024). 2024-2025 Emerging Markets Healthcare Outlook. https://speyside-group.com/news-insights/2024-2025-emerging-markets-healthcare-outlook
ResearchGate (2024). Developing countries’ health policy: A critical review and pathway to effective healthcare systems. https://www.researchgate.net/publication/377807270_Developing_countries’_health_policy_A_critical_review_and_pathway_to_effective_healthcare_systems

Ali Alqeisi is Strategic Partnerships, Marketing & Communications Manager at Emerging Health International — a healthcare transformation partner working across emerging markets to bridge the gap between strategy and real-world implementation.

For more insights on healthcare transformation in emerging markets, explore our Insights section or read our previous articles: